Literature DB >> 2297738

Patterns of antigen distribution in human carcinomas.

M J Mattes1, P P Major, D M Goldenberg, A S Dion, R V Hutter, K M Klein.   

Abstract

Ten epithelial-specific monoclonal antibodies, including monoclonal antibodies to antigens that have been used extensively in immunodiagnosis and immunotherapy experiments, were tested for reactivity with 20 human carcinomas each of the colon, lung, and breast. The antibodies tested included B72.3, OC125, and antibodies to carcinoembryonic antigen, the 17-1A antigen, and the milk fat globule mucin antigen (epithelial membrane antigen). Striking differences in the pattern of antigen distribution were seen, with each antibody having a fairly consistent staining pattern, which was dependent on the tumor type. Two antibodies reacted with most or all tumor specimens and, when positive, reacted homogeneously with apparently every cell in the specimen. Other antibodies consistently produced a variegated staining pattern, typically with areas of positive cells surrounded by areas of negative tumor cells. A third pattern was strong localization to the luminal edge and/or secretions of glandular tumors; this pattern was seen primarily in colon carcinomas which have more well-developed glandular structures than breast or lung carcinomas. A correlation with biochemical properties of the antigens was evident, in that mucins or mucin-related antigens generally produced variegated staining of lung and breast carcinomas and luminal edge/secretion staining of colon carcinomas. Such differences in antigen distribution are likely to be a major factor in developing methods for immunodiagnosis and immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297738

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Synthesis of folate-functionalized RAFT polymers for targeted siRNA delivery.

Authors:  Danielle S W Benoit; Selvi Srinivasan; Andrew D Shubin; Patrick S Stayton
Journal:  Biomacromolecules       Date:  2011-06-10       Impact factor: 6.988

2.  Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.

Authors:  Santimukul Santra; Charalambos Kaittanis; Oscar J Santiesteban; J Manuel Perez
Journal:  J Am Chem Soc       Date:  2011-09-27       Impact factor: 15.419

3.  Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.

Authors:  S J DeNardo; D L Kukis; L A Kroger; R T O'Donnell; K R Lamborn; L A Miers; D G DeNardo; C F Meares; G L DeNardo
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

Review 4.  Use of liposomes as drug delivery vehicles for treatment of melanoma.

Authors:  Melissa A Tran; Rebecca J Watts; Gavin P Robertson
Journal:  Pigment Cell Melanoma Res       Date:  2009-05-22       Impact factor: 4.693

5.  Assessment of disease activity in rheumatoid arthritis using a novel folate targeted radiopharmaceutical Folatescan.

Authors:  E L Matteson; V J Lowe; F G Prendergast; C S Crowson; K G Moder; D E Morgenstern; R A Messmann; P S Low
Journal:  Clin Exp Rheumatol       Date:  2009 Mar-Apr       Impact factor: 4.473

6.  Folate-Mediated Targeted Delivery of siPLK1 by Leucine-Bearing Polyethylenimine.

Authors:  Lu Hou; Zheyu Song; Zhonghang Xu; Yuanyu Wu; Wei Shi
Journal:  Int J Nanomedicine       Date:  2020-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.